Trial Details

COMPLETED
Basic Information
Clinical ID c4629
Identifier NCT00230581
Trial Title 8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Irritable Bowel Syndrome
Interventions DRUG: DDP225
Participant Information
Sponsor Dynogen Pharmaceuticals
City Scottsdale
Country/Region United States
Enrollment Criteria
Sex Requirement FEMALE
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2005-09
Primary Completion Date -
Completion Date 2007-08